Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Med-Pharm (BMP) was a pharmaceutical services and consumer healthcare company that specialized in the Chinese market. The company provided a range of services including market entry strategy, regulatory affairs, and contract sales and marketing for multinational pharmaceutical firms. Following its acquisition of Sunstone Pharmaceutical in 2008, it became a major player in China's over-the-counter (OTC) market with leading brands in pediatric and women's health. In 2011, the company was acquired by Sanofi for approximately $520 million to serve as a foundation for Sanofi's consumer healthcare business in China. Today, its legacy operations and brands are fully integrated into Sanofi's global consumer healthcare division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Med-Pharm Market Calculating.